ASH HIGHLIGHTS 2023 – MULTIPLE MYELOMA ROUNDTABLE DISCUSSION: RRMM Treated with Anti BCMA or Anti GPRC5D Bispecific Antibodies

Best of Oncology Podcast Series - A podcast by OncologyEducation